144 related articles for article (PubMed ID: 34799230)
1. Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice.
Verseveld M; Verver D; Noordman BJ; Pouwels S; Elferink MAG; de Graaf EJR; Verhoef C; Doornebosch PG; de Wilt JHW
Eur J Surg Oncol; 2022 May; 48(5):1153-1160. PubMed ID: 34799230
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
[No Abstract] [Full Text] [Related]
3. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
[TBL] [Abstract][Full Text] [Related]
4. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
[TBL] [Abstract][Full Text] [Related]
5. MRI cT1-2 rectal cancer staging accuracy: a population-based study.
Detering R; van Oostendorp SE; Meyer VM; van Dieren S; Bos ACRK; Dekker JWT; Reerink O; van Waesberghe JHTM; Marijnen CAM; Moons LMG; Beets-Tan RGH; Hompes R; van Westreenen HL; Tanis PJ; Tuynman JB;
Br J Surg; 2020 Sep; 107(10):1372-1382. PubMed ID: 32297326
[TBL] [Abstract][Full Text] [Related]
6. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
8. Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands.
Hagemans JAW; Alberda WJ; Verstegen M; de Wilt JHW; Verhoef C; Elferink MA; Burger JWA
Eur J Surg Oncol; 2019 Apr; 45(4):613-619. PubMed ID: 30600101
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
10. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
Calmels M; Labiad C; Lelong B; Lefevre JH; Tuech JJ; Benoist S; Mège D; Denost Q; Panis Y
Colorectal Dis; 2023 Oct; 25(10):1973-1980. PubMed ID: 37679892
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
[TBL] [Abstract][Full Text] [Related]
12. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
13. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
14. Local excision of T1 and T2 rectal cancer: proceed with caution.
Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
[TBL] [Abstract][Full Text] [Related]
15. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
17. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
19. Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.
Hazen SJA; Sluckin TC; Intven MPW; Beets GL; Beets-Tan RGH; Borstlap WAA; Buffart TE; Buijsen J; Burger JWA; van Dieren S; Furnée EJB; Geijsen ED; Hompes R; Horsthuis K; Leijtens JWA; Maas M; Melenhorst J; Nederend J; Peeters KCMJ; Rozema T; Tuynman JB; Verhoef C; de Vries M; van Westreenen HL; de Wilt JHW; Zimmerman DDE; Marijnen CAM; Tanis PJ; Kusters M;
JAMA Oncol; 2024 Feb; 10(2):202-211. PubMed ID: 38127337
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
